Evidence map›Paper›PMID 37242921›Full record

ArticlePolymers2023

Novel CuMgAlTi-LDH Photocatalyst for Efficient Degradation of Microplastics under Visible Light Irradiation.

Shengyun Jiang, Mingshan Yin, Huixue Ren, Yaping Qin, Weiliang Wang, Quanyong Wang, Xuemei Li

Abstract read
In one paragraph

Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Oxygen Vacancies Defective LaMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shengyun JiangSchool of Municipal and Environmental Engineering, Shandong Jianzhu University, Jinan 250101, China.
Mingshan YinSchool of Municipal and Environmental Engineering, Shandong Jianzhu University, Jinan 250101, China.
Huixue RenSchool of Municipal and Environmental Engineering, Shandong Jianzhu University, Jinan 250101, China.ORCID 0000-0002-5389-1084
Yaping QinSchool of Municipal and Environmental Engineering, Shandong Jianzhu University, Jinan 250101, China.
Weiliang WangBeicheng Environmental Engineering Co., Ltd., Jinan 250101, China.
Quanyong WangShandong Huacheng Urban Construction Design Engineering Co., Ltd., Jinan 250101, China.
Xuemei LiSchool of Municipal and Environmental Engineering, Shandong Jianzhu University, Jinan 250101, China.

Funding

Natural Science Foundation of Shandong Province ZR202102280483
6 · The paper itself

Abstract

Microplastics (MPs) in the water system could easily enter the human body and pose a potential threat, so finding a green and effective solution remains a great challenge. At present, the advanced oxidation technology represented by photocatalysis has been proven to be effective in the removal of organic pollutants, making it a feasible method to solve the problem of MP pollution. In this study, the photocatalytic degradation of typical MP polystyrene (PS) and polyethylene (PE) by a new quaternary layered double hydroxide composite photomaterial CuMgAlTi-R400 was tested under visible light irradiation. After 300 h of visible light irradiation, the average particle size of PS decreased by 54.2% compared with the initial average particle size. The smaller the particle size, the higher the degradation efficiency. The degradation pathway and mechanism of MPs were also studied by GC-MS, which showed that PS and PE produced hydroxyl and carbonyl intermediates in the process of photodegradation. This study demonstrated a green, economical, and effective strategy for the control of MPs in water.

Indexed as

layered double hydroxidemicroplasticsphotocatalysispolyethylenepolystyrene

Identifiers

PMID37242921
PMCPMC10224419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.